Policy Workshop: Life Sciences
Life Sciences: The Latest
  • EU Highlights
  • Viewpoints
Scientists use E.coli to generate renewable propane
Bacteria have been genetically engineered to produce propane. Now there is a challenge to scale-up the process
Harnessing biotechnology for a more sustainable economy
Taking a page out of nature’s handbook, Novozymes deploys enzymes to help (re) create a bio-based society
Tale of two biotech stars
The CEOs of Ablynx and uniQure, at a Science|Business event, tell their growth stories – and what Europe needs to do if there are to be more companies like theirs bringing new medicines to market
How to make regenerative medicine happen
Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult
Vital life sciences research is impeded by a lack of understanding of the role of patents
The uncertainty sparked by the US ruling that the BRCA1 and BRCA2 breast cancer genes are not patentable is holding back the development of diagnostics and therapies, says patent lawyer Adrian Tombling
Back small companies to deliver new medicines
Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection
Life Sciences Archive
ETH: New centre for biomedical imaging
ETH Zurich and the University of Zurich are pooling their expertise in biomedical imaging technologies. Their new competence centre EXCITE Zurich...
Scientists use E.coli to generate renewable propane
Bacteria have been genetically engineered to produce propane. Now there is a challenge to scale-up the process
£1.8 million investment boosts cutting-edge molecular science at Imperial
Local MP Mark Field visits Imperial today to launch a £1.8m upgrade to the Department of Chemistry's analytical facilities.
How to make regenerative medicine happen
Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive...
Vital life sciences research is impeded by a lack of understanding of the role of patents
The uncertainty sparked by the US ruling that the BRCA1 and BRCA2 breast cancer genes are not patentable is holding back...
Page 1 of 670> 1 2 3  ... 
Innovation in Progress - Science|Business Network
ETH: New centre for biomedical imaging
ETH Zurich and the University of Zurich are pooling their expertise in biomedical imaging technologies. Their new competence centre EXCITE Zurich aims to efficiently translate new ideas from basic research into clinical practice. The centre will be inaugurated on Saturday.
£1.8 million investment boosts cutting-edge molecular science at Imperial
Local MP Mark Field visits Imperial today to launch a £1.8m upgrade to the Department of Chemistry's analytical facilities.
Imperial's portofolio company, PsiOxus Therapeutics, initiates 'OCTAVE' study
Imperial Innovations is pleased to note that one of its portfolio of companies, PsiOxus Therapeutics, a biotechnology company developing innovative new treatments for cancer today announced the first dosing of a patient in the OCTAVE (Ovarian Cancer Treated with Adeno Vaccine Enadenotucirev) study.
Horizon 2020 Special Coverage
Universities, Businesses & Co.: Together we can (Partner Event)
Strategic inter-sectoral Partnerships for Economic and Social Change and Growth
Rome - 02 October 2014
Foresight: Europe 2030
The purpose of this event is to draw on the expertise of a group of high-level participants about how Europe is...
Berlin - 06 October 2014
The Future of Europe is Science (Partner Event)
Bringing together actors from the world of science, industry and society, the two-day conference aims to take stock of European achievements...
Lisbon - 06 October 2014
Unlocking the value of Personalised Healthcare in Europe
This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.
Bigger and Simpler: A short guide to the EU's €80 billion Horizon 2020 programme
A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission's plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth.
Biofuels: The Next Generation
Key ideas and recommendations to accelerate the deployment of sustainable biofuels have emerged at the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference
Advertisement